B Cell Depletion Delays Collagen-Induced Arthritis in Mice : Arthritis Induction Requires Synergy between Humoral and Cell-Mediated Immunity 1

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• B‐lymphocyte depletion ameliorates Sjögren's syndrome in Id3 knockout mice

  2007cited by this paper
• Reconstitution of peripheral blood B cells after depletion with rituximab in patients with rheumatoid arthritis.

  2006cited by this paper
• B cell depletion therapy in systemic rheumatic diseases: different strokes for different folks?

  2006cited by this paper
• Antibody isotype-specific engagement of Fcγ receptors regulates B lymphocyte depletion during CD20 immunotherapy

  2006cited by this paper
• Fcγ receptor-dependent effector mechanisms regulate CD19 and CD20 antibody immunotherapies for B lymphocyte malignancies and autoimmunity

  2006cited by this paper
• Primary T Cell Expansion and Differentiation In Vivo Requires Antigen Presentation by B Cells1

  2006cited by this paper
• New prospects for autoimmune disease therapy: B cells on deathwatch.

  2006cited by this paper
• B-lymphocyte depletion reduces skin fibrosis and autoimmunity in the tight-skin mouse model for systemic sclerosis.

  2006cited by this paper
• B-cell depletion inhibits arthritis in a collagen-induced arthritis (CIA) model, but does not adversely affect humoral responses in a respiratory syncytial virus (RSV) vaccination model.

  2005cited by this paper
• Genetically based resistance to the antiinflammatory effects of methotrexate in the air-pouch model of acute inflammation.

  2005cited by this paper
• B cells: a fundamental role in the pathogenesis of rheumatoid arthritis?

  2005cited by this paper
• The Peritoneal Cavity Provides a Protective Niche for B1 and Conventional B Lymphocytes during Anti-CD20 Immunotherapy in Mice1

  2005cited by this paper
• Collagen type II (CII)-specific antibodies induce arthritis in the absence of T or B cells but the arthritis progression is enhanced by CII-reactive T cells

  2004influential reference
• The Innate Mononuclear Phagocyte Network Depletes B Lymphocytes through Fc Receptor–dependent Mechanisms during Anti-CD20 Antibody Immunotherapy

  2004cited by this paper
• Mouse CD20 expression and function.

  2004cited by this paper
• Enhancement of collagen-induced arthritis in mice genetically deficient in extracellular superoxide dismutase.

  2004cited by this paper
• B cell‐dependent T cell development

  2004cited by this paper
• Pathogenic roles of B cells in human autoimmunity; insights from the clinic.

  2004cited by this paper
• Distinct Profiles of Human B Cell Effector Cytokines: A Role in Immune Regulation?1

  2004cited by this paper
• Divergent Pro- and Antiinflammatory Roles for IL-23 and IL-12 in Joint Autoimmune Inflammation

  2003cited by this paper
• Evolving concepts of rheumatoid arthritis

  2003cited by this paper
• Rituximab (monoclonal anti-CD20 antibody): mechanisms of action and resistance

  2003cited by this paper
• Serologic changes following B lymphocyte depletion therapy for rheumatoid arthritis.

  2003cited by this paper
• Costimulation via OX40L Expressed by B Cells Is Sufficient to Determine the Extent of Primary CD4 Cell Expansion and Th2 Cytokine Secretion In Vivo

  2003cited by this paper
• Morphological and molecular pathology of the B cell response in synovitis of rheumatoid arthritis

  2002cited by this paper
• Development of Inflammation in Proteoglycan-Induced Arthritis Is Dependent on FcγR Regulation of the Cytokine/Chemokine Environment1

  2002cited by this paper
• Autoantibodies in rheumatoid arthritis and their clinical significance

  2002cited by this paper
• Rituximab treatment results in impaired secondary humoral immune responsiveness.

  2002cited by this paper
• The Importance of IL-1β and TNF-α, and the Noninvolvement of IL-6, in the Development of Monoclonal Antibody-Induced Arthritis

  2002cited by this paper
• B cells regulate autoimmunity by provision of IL-10

  2002cited by this paper
• Immunotherapy of Non-Hodgkin's lymphomas.

  2001cited by this paper
• Lymphoid Neogenesis in Rheumatoid Synovitis1

  2001cited by this paper
• Antigen presentation of Type II collagen in rats

  2001cited by this paper
• T Cell Activation in Rheumatoid Synovium Is B Cell Dependent1

  2001cited by this paper
• Rituximab anti-CD20 monoclonal antibody therapy in non-Hodgkin's lymphoma: safety and efficacy of re-treatment.

  2000cited by this paper
• Delayed onset and reduced severity of collagen-induced arthritis in interleukin-6-deficient mice

  2000cited by this paper
• Evaluation of TNF-α and IL-1 Blockade in Collagen-Induced Arthritis and Comparison with Combined Anti-TNF-α/Anti-CD4 Therapy1

  2000cited by this paper
• Methotrexate specifically modulates cytokine production by T cells and macrophages in murine collagen‐induced arthritis (CIA): a mechanism for methotrexate‐mediated immunosuppression

  1999cited by this paper
• Acceleration and increased severity of collagen-induced arthritis in P-selectin mutant mice.

  1999cited by this paper
• B cell‐deficient mice do not develop type II collagen‐induced arthritis (CIA)

  1998cited by this paper
• Correlation between IgG anti-type II collagen levels and arthritic severity in murine arthritis.

  1998cited by this paper
• Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program.

  1998cited by this paper
• Soluble IL-15 receptor alpha-chain administration prevents murine collagen-induced arthritis: a role for IL-15 in development of antigen-induced immunopathology.

  1998cited by this paper
• Clinical status and optimal use of rituximab for B-cell lymphomas.

  1998cited by this paper
• Analogues of methotrexate in rheumatoid arthritis. 2. Effects of 5-deazaaminopterin, 5,10-dideazaaminopterin, and analogues on type II collagen-induced arthritis in mice.

  1997cited by this paper
• Accelerated collagen-induced arthritis in IFN-gamma receptor-deficient mice.

  1997cited by this paper
• Interleukin-12: an immunoregulatory cytokine produced by B cells and antigen-presenting cells.

  1997cited by this paper
• Reduced susceptibility to collagen-induced arthritis in mice deficient in intercellular adhesion molecule-1.

  1996cited by this paper
• CD19 regulates B lymphocyte signaling thresholds critical for the development of B-1 lineage cells and autoimmunity.

  1996cited by this paper
• Quantitative analysis of the influenza virus-specific CD4+ T cell memory in the absence of B cells and Ig.

  1996cited by this paper
• Antibodies to type II collagen in early rheumatoid arthritis. Correlation with disease progression.

  1996cited by this paper
• Successful T cell priming in B cell-deficient mice

  1995cited by this paper
• Abnormal B lymphocyte development, activation, and differentiation in mice that lack or overexpress the CD19 signal transduction molecule.

  1995cited by this paper
• Expression of a transgenic class II Ab gene confers susceptibility to collagen‐induced arthritis

  1994cited by this paper
• CD20: a regulator of cell-cycle progression of B lymphocytes.

  1994cited by this paper
• Genes on the X chromosome affect development of collagen‐induced arthritis in mice

  1993cited by this paper
• Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis.

  1992influential reference
• Clinical significance of rheumatoid factors in early rheumatoid arthritis: results of a follow up study.

  1992cited by this paper
• PREVENTION OF COLLAGEN INDUCED ARTHRITIS IN MICE BY TREATMENT WITH AN ANTIBODY DIRECTED AGAINST THE T CELL RECEPTOR αβ FRAMEWORK

  1992cited by this paper
• Arthritis in DBA/1 Mice Induced with Passively Transferred Type II Collagen Immune Serum

  1990cited by this paper
• Lymphocyte subsets in the blood: a diagnostic window on the lymphoid system?

  1990cited by this paper
• HLA-DR4 subtype frequencies in rheumatoid arthritis indicate that DRB1 is the major susceptibility locus within the HLA class II region.

  1989cited by this paper
• Type II collagen-induced murine arthritis. I. Induction and perpetuation of arthritis require synergy between humoral and cell-mediated immunity.

  1988cited by this paper
• Antigen Uptake and Accumulation in Antigen‐Specific B Cells

  1987cited by this paper
• Role of T lymphocytes in murine collagen induced arthritis

  1986cited by this paper
• Prevention of type II collagen-induced arthritis by in vivo treatment with anti-L3T4

  1985cited by this paper
• Incidence of arthritis and autoreactivity of anti-collagen antibodies after immunization of DBA/1 mice with heterologous and autologous collagen II.

  1985cited by this paper
• T Lymphocytes in Collagen II‐Induced Arthritis in Mice

  1985cited by this paper
• Humoral and cellular immunologic responses in collagen-induced arthritis in rats: their correlation with severity of arthritis.

  1984cited by this paper
• Serum transfer of collagen-induced arthritis in mice

  1983cited by this paper
• [Rheumatoid arthritis].

  1983cited by this paper
• RHEUMATOID ARTHRITIS: A DISEASE OF T-LYMPHOCYTE/MACROPHAGE IMMUNOREGULATION

  1981cited by this paper
• Immunisation against heterologous type II collagen induces arthritis in mice

  1980cited by this paper
• Anti-collagen antibodies in sera from rheumatoid arthritis patients.

  1980cited by this paper
• Autoimmunity to type II collagen an experimental model of arthritis

  1977cited by this paper
• Antibodies to human native and denatured collagens in synovial fluids of patients with rheumatoid arthritis.

  1976cited by this paper

• No citing papers are available for this paper.